Sources | Names Used |
---|---|
CTRPv2 | salermide:PLX-4032 (12:1 mol/mol) |
PharmacoGx | salermide:PLX-4032 (12:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ITGB3 | CTRPv2 | pan-cancer | AAC | 0.31 | 8e-13 |
mRNA | SOX10 | CTRPv2 | pan-cancer | AAC | 0.42 | 8e-13 |
mRNA | SLC23A2 | CTRPv2 | pan-cancer | AAC | 0.29 | 1e-12 |
mRNA | S100B | CTRPv2 | pan-cancer | AAC | 0.28 | 2e-12 |
mRNA | RXRG | CTRPv2 | pan-cancer | AAC | 0.29 | 3e-12 |
mRNA | PLP1 | CTRPv2 | pan-cancer | AAC | 0.32 | 3e-12 |
mRNA | MYL10 | CTRPv2 | pan-cancer | AAC | 0.25 | 4e-12 |
mRNA | RP11-290H9.2 | CTRPv2 | pan-cancer | AAC | 0.3 | 4e-12 |
mRNA | APOD | CTRPv2 | pan-cancer | AAC | 0.25 | 4e-12 |
mRNA | S100A1 | CTRPv2 | pan-cancer | AAC | 0.28 | 9e-12 |